Sexual function matters to people living with serious mental illness

bryan-apen-567698-unsplash

Rudiger Pittrof and Elana Covshoff from SHRINE (Sexual and Reproductive Health Rights, Inclusion and Empowerment) explore a recent review, which looks at the impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

[read the full story...]

Non-medical use of prescription drugs #NonMedicalDrugs

playmobil-451203_1280

Ian Hamilton and Julia Buxton from the University of York preview the #NonMedicalDrugs event that will take place in York on Friday 16th March 2018.

The meeting will bring together people who can offer personal and professional insights of the extent of the issue and how we can support people who develop problems.

[read the full story...]

Burning mouth syndrome: insufficient evidence for effectiveness of current treatments

Depression

This update of a 2005 Cochrane review identified 23 RCTs but a limited number at low risk of bias so there is insufficient evidence to support or refute the use of any interventions in managing burning mouth syndrome.

[read the full story...]

Self-harm on the rise, but many denied mental health assessments

16343726933_6212d82a2d_k

Katrina Witt explores a recently published paper that draws on the Multicentre Study of Self-Harm in England. The cohort study found that around one-half of self-harm patients do not receive psychosocial assessment, despite 2004 NICE guidance that recommends everyone who has self-harmed should have a comprehensive assessment of needs and risk.

[read the full story...]

Cochrane find no evidence for as required PRN medication for mental health inpatients

4711660113_49676b8c32_b

John Baker summarises an updated Cochrane review on ‘as required’ PRN medication regimens for seriously mentally ill people in hospital, which finds no randomised controlled trials that support this widely used intervention.

[read the full story...]

Commonly prescribed psychiatric drugs: do they work?

4932655275_7811863fe8_o

John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.

[read the full story...]

CBT plus taper may help reduce short-term benzodiazepine use

8119248181_d492e64f47_k

John Baker summarises a recent Cochrane systematic review of psychosocial interventions for benzodiazepine harmful use, abuse or dependence.

[read the full story...]

Antidepressant withdrawal syndromes: time to grasp the nettle?

shutterstock_159290282

Andrew Shepherd appraises and summarises a systematic review of antidepressant withdrawal symptoms after SSRI discontinuation, which leads him to reconsider his own clinical practice.

[read the full story...]

CBT for insomnia in psychiatric populations: an effective alternative to hypnotics?

shutterstock_sheep asleep

Amy Green appraises a systematic review of CBT for insomnia (CBTi) in people with comorbid mental illness, which concludes that cognitive behaviour therapy could be an effective alternative to hypnotics. However, concerns about the review methodology cast some doubt on the findings.

[read the full story...]

Reducing benzodiazepine prescribing in primary care

shutterstock_69687928

Liz Hughes summarises two recent studies (1 systematic review and 1 RCT) that both investigate brief interventions for reducing the use of benzodiazepines in primary care.

[read the full story...]